As of 2025-07-16, the Intrinsic Value of Advanced Enzyme Technologies Ltd (ADVENZYMES.NS) is 174.11 INR. This ADVENZYMES.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 322.25 INR, the upside of Advanced Enzyme Technologies Ltd is -46.00%.
The range of the Intrinsic Value is 144.99 - 221.50 INR
Based on its market price of 322.25 INR and our intrinsic valuation, Advanced Enzyme Technologies Ltd (ADVENZYMES.NS) is overvalued by 46.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 144.99 - 221.50 | 174.11 | -46.0% |
| DCF (Growth 10y) | 177.59 - 266.72 | 211.95 | -34.2% |
| DCF (EBITDA 5y) | 364.00 - 482.98 | 407.28 | 26.4% |
| DCF (EBITDA 10y) | 324.32 - 469.62 | 380.11 | 18.0% |
| Fair Value | 58.60 - 58.60 | 58.60 | -81.82% |
| P/E | 334.06 - 416.50 | 370.25 | 14.9% |
| EV/EBITDA | 245.80 - 372.90 | 301.34 | -6.5% |
| EPV | 93.14 - 116.25 | 104.69 | -67.5% |
| DDM - Stable | 55.45 - 116.53 | 85.99 | -73.3% |
| DDM - Multi | 121.52 - 193.52 | 148.93 | -53.8% |
| Market Cap (mil) | 36,053.33 |
| Beta | 1.55 |
| Outstanding shares (mil) | 111.88 |
| Enterprise Value (mil) | 35,369.98 |
| Market risk premium | 8.31% |
| Cost of Equity | 15.92% |
| Cost of Debt | 7.81% |
| WACC | 15.79% |